| Hb < 100 g/l during pregnancy N = 39 | Hb ≥ 100 g/l during pregnancy N = 1182 | B/ORa | CI 95% | p-value |
---|---|---|---|---|---|
Antenatal depressive symptoms | |||||
 EPDS  Early pregnancy | 5.0 (2–18) | 5.0 (0–27) | 0.99 | -0.62–2.60 | 0.226 |
 EPDS  Mid-pregnancy | 6.5 (1–20) | 4.0 (0–25) | 1.63 | -0.08–3.33 | 0.062 |
 EPDS  Late pregnancy | 5.8 (2–15) | 4.0 (0–19) | 1.70 | -0.14–3.54 | 0.070 |
 EPDS ≥ 10  Late pregnancy | 5/18 (27.8%) | 112 (13.2%) | OR 1.78 | 0.55–5.81 | 0.336 |
Postpartum depressive symptoms | |||||
 EPDS  3 months postpartum | 5.0 (0–10) | 3.0 (0–21) | 1.22 | -0.57–3.00 | 0.182 |
 EPDS  6 months postpartum | 4.0 (0–14) | 3.0 (0–23) | 0.38 | -1.67–2.43 | 0.715 |
 EPDS ≥ 10  3 months postpartum | 3/19 (15.8%) | 69 (9.5%) | OR 1.90 | 0.52–6.94 | 0.328 |
 EPDS ≥ 10  6 months postpartum | 2/17 (11.8%) | 69 (11.2%) | OR 0.78 | 0.17–3.58 | 0.748 |
Antenatal general and pregnancy-related anxiety symptoms | |||||
 SCL  Early pregnancy | 3.0 (0–14) | 2.0 (0–28) | 0.77 | -0.81–2.35 | 0.339 |
 SCL  Mid-pregnancy | 4.5 (0–15) | 3.0 (0–29) | 1.64 | -0.15–3.43 | 0.073 |
 SCL  Late pregnancy | 5.5 (0–14) | 2.0 (0–27) | 2.10 | 0.22–3.98 | 0.028* |
 PRAQ  Early pregnancy | 24.5 (11–40) | 22.0 (11–45) | 1.73 | -10.65–14.10 | 0.783 |
 PRAQ  Mid-pregnancy | 27.0 (12–34) | 23.0 (10–46) | 1.89 | -0.97–4.76 | 0.195 |
 PRAQ  Late pregnancy | - | 23.0 (10–50) |  |  |  |
Postnatal anxiety symptoms | |||||
 SCL  3 months postpartum | 2.0 (0–9) | 1.0 (0–24) | 0.97 | -0.69–2.64 | 0.252 |
 SCL  6 months postpartum | 2.0 (0–13) | 1.0 (0–29) | 1.24 | -0.72–3.19 | 0.214 |